RE-ENGINEERING THE CLINICAL RESEARCH ENTERPRISE Working Groups and Co-Chairs Co-Chairs Stephen Katz, NIAMS Stephen E. Straus, NCCAM Subgroups Harmonization.

Slides:



Advertisements
Similar presentations
The NIH Roadmap for Medical Research
Advertisements

The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
1 FDA Industry Workshop Statistics in the FDA & Industry The Future David L DeMets, PhD Department of Biostatistics & Medical Informatics University of.
The Readiness Centers Initiative Early Education and Care Board Meeting Tuesday, May 11, 2010.
A Vision for Clinical and Translational Research Presentation to the Clinical Research Seminar The University of Oklahoma Health Sciences Center Barbara.
Local Immigration Partnerships: Systems Planning to Help People.
Research Administration Capacity Building in an Established Institution Presenter: M.M.Aboud, MD Director of Research and Publications, MUHAS.
A Vision for Clinical and Translational Research Presentation to the Clinical Research Seminar The University of Oklahoma Health Sciences Center Barbara.
National Cardiovascular Research Infrastructure (NCRI) Summary Slide Set May 5, 2010.
Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.
Individualized Learning Plans A Study to Identify and Promote Promising Practices.
The Next Generation of Outcomes Researchers – Directions for Training AHA 2013 November 18, 2013 Tracy Y. Wang, MD, MHS, MSc.
National Institute on Aging Judith A. Salerno, M.D., M.S. Deputy Director NIA/NIH/DHHS ADC Meeting April 2004.
“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.
RM DYNAMIC ASSESSMENT OF PATIENT-REPORTED CHRONIC DISEASE OUTCOMES Pre-Application Meeting January 26, 2004 Rockville, MD.
CEC Advisory Council October 25, 2013 Miami 2020 Plan: Moments that Transorm.
The NIH Roadmap.
Helena Chui, M.D. McCarron Professor and Chair of Neurology Director, Alzheimer Disease Research Center.
1 NIH Clinical Center,CTSAs NIH Molecular Libraries Initiative Disease Target ID Assay Dev. HTS Probe to Lead Pre- Clinical FDA IND Ph. IPh. IIPh. III.
National Institute on Aging Richard J. Hodes, M.D. Director,NIA/NIH/DHHS ADC Meeting – NIH Roadmap and Budget October 2003.
October 19, 2010 Steven Hirschfeld, MD, PhD Julia Slutsman, PhD
Produce Safety Rule Phase 2 Workgroup 1.
Capacity Task Force Virginia Health Reform Initiative January 14, 2011
RESEARCH TEAMS OF THE FUTURE Working Groups and Co-Chairs  Interdisciplinary Research Patricia Grady, NINR Ken Olden, NIEHS Larry Tabak, NIDCR  High-risk.
The NIH Roadmap for Medical Research
Research Bioethics Consultation: More potential than sequencing genomes Benjamin S. Wilfond MD Seattle Children’s Hospital Treuman Katz Center for Pediatric.
National Health Information Infrastructure “Person(al)” Health This presentation does not necessarily reflect the view of the U.S. Government or the Institution.
GROUP 1 PRESENTATION Aisa Bernante Princess Diane Bernales Simplicio Palado.
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
HRSA’s Oral Health Goals and the Role of MCH Stephen R. Smith Senior Advisor to the Administrator Health Resources and Services Administration.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.
NIH Perspectives on Adverse Event Reporting: Looking to the Future VA IRB Chair Training Session April 8, 2004.
Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated.
Certification & Training Assessment Group History & Current Activity North Central Region Pesticide Education & Certification Workshop June 2002.
Investigational New Drug Application (IND)
Connecting South Carolina: The Gibbs/Hollings Cancer Center An NCCCP/NCI Designated Center Connection Anita L. Harrison, MPH Associate Director, Administration.
Responsible Conduct of Research (RCR) What is RCR? New Requirements for RCR Who Does it Affect? When? Data Management What is the Institutional Plan? What.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Yale Center for Clinical Investigation: Academic Home to the CTSA Secretary’s Advisory Committee on Human Research Protections (SACHRP) Presentation Tesheia.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
11/2003 CML Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may.
Systems Approaches to Population Health. Activities Supported by NCI.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
National Center for Research Resources G. Iris Obrams, M.D., M.P.H., Ph.D. NCRR Update 5 August 2006.
Integrating a Federated Healthcare Data Query Platform With Electronic IRB Information Systems Shan He IPHIE 2010.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.
NIH and the Clinical Research Enterprise Third Annual Medical Research Summit March 6, 2003 Mary S. McCabe National Institute of Health.
Overview of ONC Report to Congress on Health Information Blocking Presented to the Health IT Policy Committee, Task Force on Clinical, Technical, Organizational,
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
1 25 STRONG WORKFORCE RECOMMENDATIONS IMPLEMENTATION OVERVIEW #strongworkforce DoingWhatMATTERS.cccco.edu.
Bridgewater-Raritan Regional School District Program Evaluations A summary of recommendations from the completed program evaluations March 6, 2009.
AACN – Manatt Study In February 2015, the AACN Board of Directors commissioned Manatt Health to conduct a study on how to position academic nursing to.
© 2014 By Katherine Downing, MA, RHIA, CHPS, PMP.
OVERVIEW OF THE WORKFORCE DEVELOPMENT DOMAIN TASK FORCE APRIL 16, 2015 Joan D. Nagel, M.D., M.P.H. Program Director, Division of Clinical Innovation National.
I farmaci innovativi in una prospettiva europea Giuseppe M.C. Rosano, MD, PhD Cardiovascular and Cell Sciences Research Institute, St George's University.
Translational Research Why should you care about translational research? The public cares. Translation into therapies justifies spending on science.
The Essentia Institute of Rural Health (EIRH) is
Novartis Pediatric Drug Development Faculty Program
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
How to Write a Successful NIH Career Development Award (K Award)
September 7, 2018 Courtney Baird, MS
Medical Research Funding and Regulation Third Annual Medical Research Summit March 6, 2003 Mary S. McCabe National Institutes of Health.
Clinical and Translational Science Awards Program
Clinical and Translational Science Scholars Program
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Presentation transcript:

RE-ENGINEERING THE CLINICAL RESEARCH ENTERPRISE Working Groups and Co-Chairs Co-Chairs Stephen Katz, NIAMS Stephen E. Straus, NCCAM Subgroups Harmonization of Clinical Research Regulatory Processes Amy Patterson, OSP Integration of Clinical Research Networks, including NECTAR Larry Friedman, NHLBI Stephen Katz, NIAMS Enhance Clinical Research Workforce Training Duane Alexander, NICHD Rob Star, NIDDK Enabling Technologies for Improved Assessment of Clinical Outcomes Deborah Ader, NIAMS Larry Fine, OBSSR Stephen Katz, NIAMS Regional Translational Research Centers Stephen E. Straus, NCCAM Steve Zalcman, NIMH Translational Research Service Cores Josephine Briggs, NIDDK Stephen E. Straus, NCCAM

Re-engineering the Clinical Research Enterprise Stephen Katz, M.D., Ph.D Amy Patterson, M.D. Stephen E. Straus, M.D.

BenchBedsidePractice Building Blocks and Pathways Molecular Libraries Bioinformatics and Computational Biology Structural Biology Nanomedicine Translational Research Cores Regional Centers Interdisciplinary Research Pioneer Award Public-Private Partnerships Cross cutting: Harmonization, Training Integrated Research Networks Clinical Research Informatics National Clinical Research Associates Patient-reported clinical outcomes Re-engineering Clinical Research

Integration of Clinical Research Networks Link existing networks so clinical studies and trials can be conducted more effectively Ensure that patients, physicians and scientists form true Communities of Research

Typical NIH Network Academic Health Center Sites & Data Coordinating Center

Interoperable Networks Share Sites and Data

Integration of Clinical Research Networks Create interoperable Network of Networks National Electronic Clinical Trials/Research Network (NECTAR) Common data standards, informatics Software application tools for Protocol preparation, IRB management, adverse event reports Use existing networks to rapidly address questions beyond their traditional scope BAA-RM-04-23: Feasibility of Integrating and Expanding Clinical Research Networks Inventory and Evaluation of Clinical Research Networks: NIH Task Order 169

NIH Career Development Programs College Professional Post-Doc Prof. Advancement Grad School NIH CR Training Program; Trans-NIH K12 CR Career Dev; Advanced Degree Program? National CR Associates Program

Trans-NIH Multidisciplinary K12 Career Development Program (RFA) Goal: Promote development of investigators from a variety of disciplines (M.D., Ph.D., R.N.-Ph.D., D.P.H., Pharm.D., D.C., …) To be trained in multidisciplinary team settings Features: Up to 5 years of training Core didactic courses, Project-specific training Mentored research experience in team settings Faculty and mentor support to protect their time Tuition support Annual meetings

National Clinical Research Associates Goal: Diverse national group of trained and certified community healthcare providers Will enroll and follow their own patients Accelerate translation of results into practice Steps: Determine feasibility: Barriers? Communities? Incentives needed? Inventory training methods, best practices Develop core competencies, certification Future: Training programs

Dynamic Assessment of Patient- Reported Chronic Disease Outcomes Background: Assessment of chronic diseases relies heavily on subjective reports of symptoms and health related quality of life items PROMIS – Patient-Reported Outcomes Measurement Information System: A collaborative network of investigators charged to develop and implement a publicly available system of a large item bank and a Computerized Adaptive Tests for more sensitive and efficient testing of major chronic disease symptoms and functioning. RFA-RM : Dynamic Assessment of Patient-Reported Chronic Disease Outcomes

BenchBedsidePractice Building Blocks and Pathways Molecular Libraries Bioinformatics and Computational Biology Structural Biology Nanomedicine Translational Research Cores Regional Centers Interdisciplinary Research Pioneer Award Public-Private Partnerships Cross cutting: Harmonization, Training Integrated Research Networks Clinical Research Informatics National Clinical Research Associates Patient-reported clinical outcomes Re-engineering Clinical Research

Clinical Research Policy Analysis and Coordination Harmonization Initiative

Clinical Research: Navigating the Roadway Clinical research impeded by multiple and variable requirements to address fundamentally the same oversight concerns Variability among and within agencies Creates uncertainty about how to comply Hampers efficiency and effectiveness

Clinical Research Policy Analysis and Coordination Initiative AIM:Promote clear, effective, and coordinated policies and regulations for the conduct and oversight of clinical research

Priority Issues 1. Diverse adverse event reporting requirements 2. Confusion regarding roles and responsibilities of Data Safety and Monitoring Boards, IRBs, and other review mechanisms 3. Variable requirements for auditing and monitoring of clinical trials 4. Absence of uniform standards for electronic submission of safety and clinical research information

Priority Issues 5. Confusion regarding applicability of privacy requirements and HIPAA to clinical research 6. Variability in interpretation of the human subjects regulations 7. Central vs. local IRB review 8. Best practices in informed consent 9. Investigator financial disclosure and conflicts of interest

Methods Establish formal NIH program to: Work in concert with sibling agencies to catalyze the federal-wide coordination of policies pertaining to clinical research Consult with key stakeholders including IRB, patient, industry, and research communities Develop tools and resources to facilitate understanding of and compliance with clinical research policies and requirements

Harmonized Adverse Event Reporting Requirements Gene Therapy Example Prior to January 2002: Principal Investigators had to report to NIH all serious adverse events immediately At variance with FDA requirements (21 CFR 312) Current harmonized requirement: Possibly associated, unexpected events reported within 15 days - or within 7 days if fatal or life threatening Scope, timeframe, and definitions for safety reporting are same for NIH and FDA

Analysis and Communication of CR Information Prevailing paradigm Paper based Varied information and diverse formats and vocabularies Inefficient transmission and limited comparison of data sets Model approach Electronic data capture, analysis and reporting Uniform data elements and format accepted by multiple agencies Rapid transmission and ready comparison of data sets Objectives Facilitate investigator compliance Enhance agency oversight Optimize data sharing and analysis

Clear, effective, and coordinated rules for clinical research Maximally effective human subjects protections More comprehensive analysis and sharing of research data Enhanced quality and productivity of the research enterprise Outcomes

Translational Research Definition: Research at the bench-bedside interface designed to define disease pathobiology and to explore innovative approaches to treatment and prevention A Problem: Academic investigators too often lack the resources and expertise to study diseases or evaluate novel drugs and biologics in early phase (I-II) human studies using state- of-the-art tools

BenchBedsidePractice Building Blocks and Pathways Molecular Libraries Bioinformatics and Computational Biology Structural Biology Nanomedicine Translational Research Cores Regional Centers Interdisciplinary Research Pioneer Award Public-Private Partnerships Cross cutting: Harmonization, Training Integrated Research Networks Clinical Research Informatics National Clinical Research Associates Patient-reported clinical outcomes Facilitating Translational Research

Translational Research: Goals for the Initiatives Stimulate research at the bench-bedside interface Implement mechanisms to prepare novel products for pre-clinical and clinical studies Ensure adequate support for regulatory oversight, data management, and specimen analyses Increase the sensitivity and impact of early phase clinical studies Invest sufficiently in a modest number of programs to facilitate research at many institutions

Translational Research Core Services Extensive consultations with leaders in academia and industry Pilot program will support early pre-clinical development of small molecules for therapeutic applications Modeled on NCI RAID program – Provides investigators access to contractor facilities for key services Requires extensive decision-making expertise, process controls, and regulatory oversight Funded ~25% by Roadmap; ~75% by sponsoring IC Current status: Pilot initiative for implementation in FY2005

Regional Translational Research Centers Current options for resources: Regulatory, statistical, bioethics & data management support Support bench-to-bedside and pilot projects, translational research fellows program Cores in some sites for pharmacology, immunology, genetics, microarray, bioinformatics and other highly technical services Could complement NCRRs GCRC program, and support phase I studies of products made by the Core Services program Next Steps: National meeting of academic opinion leaders in summer 2004 Goal is to call for and fund planning grants in FY2005, and rounds of new centers starting in FY2006

BenchBedsidePractice Building Blocks and Pathways Molecular Libraries Bioinformatics and Computational Biology Structural Biology Nanomedicine Translational Research Cores Regional Centers Interdisciplinary Research Pioneer Award Public-Private Partnerships Cross cutting: Harmonization, Training Integrated Research Networks Clinical Research Informatics National Clinical Research Associates Patient-reported clinical outcomes Re-engineering Clinical Research

Re-engineering Clinical Research: A Work in Progress

Re-engineering Clinical Research: Progress To Date (as of February 2004) Multidisciplinary Clinical Research Career Development (K12) programs: RFA-RM Dynamic Assessment of Patient-Reported Chronic Disease Outcomes: RFA-RM Inventory and Evaluation of Clinical Research Networks: NIH task order 169 Feasibility of Integrating and Expanding Clinical Research Networks: BAA-RM-04-23

Re-engineering Clinical Research: Future 05 Initiatives Translational Research Translational Research Core Services pilot program Planning grants for Regional Translational Research Centers Clinical Research Feasibility of the National Clinical Research Associates program

Ideas People Resources Leadership NIH